Novartis names Indian-origin Vasant Narasimhan as new CEO | Mint
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
The 'student' of leadership who seeks to inspire his employees | Financial Times
Vasant Narasimhan to Succeed Joseph Jimenez as CEO Novartis - IndiaMedToday
Novartis CEO Says FDA Process Could Have Been Handled Better - Bloomberg
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
Vasant Narasimhan | Novartis
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
Novartis CEO Continues Shake-Up, Says Will Save More Than $1 Billion Annually | Barron's
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune
It was never my plan to be the boss of a huge company' - BBC News
Vas Narasimhan | Fortune
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times
Interview: Vas Narasimhan, the 'unboss' of Novartis | Business | The Sunday Times
Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' - The New York Times
Vas Narasimhan: the American trying to reshape Novartis | Financial Times
Novartis's new chief sets sights on 'productivity revolution' | Financial Times
Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis | Business Standard News
Vas Narasimhan Biography - Facts, Childhood, Family Life & Achievements of CEO of Novartis.
Vas Narasimhan Biography - Facts, Childhood, Family Life & Achievements of CEO of Novartis.
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
News: Indian-origin Vasant Narasimhan appointed as the new CEO of Novartis — People Matters
Novartis sees strong interest in Sandoz generics unit - Finanz und Wirtschaft | Reuters
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' - The New York Times
